Trial on Cyclosporine A and Natamycin for Fungal Keratitis
A clinical trial is investigating the efficacy of adjunctive topical Cyclosporine A eye drops with Natamycin for fungal keratitis.
Asset / Drug
Drug and asset intelligence for Natamycin with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.